Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06385184 · ClinicalTrials.gov registry record

Social & QoL Behaviors in Parkinson's Disease

A clinical trial of Parkinson Disease, sponsored by Gregory Wallace.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT06385184: Recruiting study of Parkinson Disease, sponsored by Gregory Wallace.

NCT06385184 is a study of Parkinson Disease that is actively recruiting participants, run by Gregory Wallace. The registered enrollment target is 500 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06385184, a study of Parkinson Disease, is actively recruiting participants, sponsored by Gregory Wallace.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.

Primary Outcome

satisfaction with different aspects of life, such as health and social relationships

Conditions Studied

Parkinson Disease

Interventions

  • OTHER No Intervention

Study Locations (1)

District of Columbia

  • The George Washington University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-03-08
Est. Completion 2027-12-31
Gregory Wallace

1 total trials

What NCT06385184 shows while recruiting

NCT06385184 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT06385184 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06385184 about?

NCT06385184 is a clinical study titled "Social & QoL Behaviors in Parkinson's Disease". Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (...

What is the current status of trial NCT06385184?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-03-08. Estimated completion is 2027-12-31.

What conditions does trial NCT06385184 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06385184?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT06385184?

This trial is sponsored by Gregory Wallace, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06385184 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06385184's enrollment target sits among peer trials

500 23rd of 297 higher than 274 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06385184

Source: ClinicalTrials.gov NCT06385184, the US trial registry maintained by the National Library of Medicine. NCT06385184 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.